Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline
Head & Neck · 2023
DOI: 10.1002/hed.27462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Qian Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sci…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Paranasal Sinus Neoplasms. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Identifying the lymph node target volume in patients with node‐negative sinonasal squamous cell carcinoma (SNSCC) crossing the midline poses a challenge. This study aims to address this.
Methods
We retrospectively reviewed clinically N0 patients with tumors crossing the midline who received elective neck irradiation (ENI) from two centers between 1999 and 2019. The main endpoint was regional relapse‐free survival (RRFS).
Results
We included 104 patients: 64 received bilateral ENI, and 40 received ipsilateral‐only ENI (median follow‐up time was 89.99 and 95.01 months, respectively). At 5 years, the RRFS rates were comparable (57.68% vs. 55.83%, p = 0.372), as were the contralateral RRFS (57.68% vs. 61.62%, p = 0.541). Five‐year OS, LRFS, and DMFS showed no significant difference between two groups.
Conclusions
Our findings provide preliminary evidence suggesting the potential for avoiding contralateral ENI in SNSCC patients with midline crossing tumors who undergo ipsilateral ENI, covering at least level II. Validation through future prospective studies is necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Head and Neck Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
ORCID-Profile: Qian Liu, Zekun Wang, Jingbo Wang, Ye Zhang, Junlin Yi, Jingwei Luo
Zitieren
APA
Liu, Q., Lun, L., Sun, M., Wang, Z., Qu, Y., Huang, X., Chen, X., Wang, J., Zhang, J., Wang, K., Wu, R., Zhang, Y., Yi, J., & Luo, J. (2023). Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline. Head & Neck. https://doi.org/10.1002/hed.27462
Vancouver
Liu Q, Lun L, Sun M, Wang Z, Qu Y, Huang X, et al. Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline. Head & Neck. 2023. doi:10.1002/hed.27462
BibTeX
@article{Liu2023,
author = {Liu, Qian and Lun, Lixin and Sun, Meng and Wang, Zekun and Qu, Yuan and Huang, Xiaodong and Chen, Xuesong and Wang, Jingbo and Zhang, Jianghu and Wang, Kai and Wu, Runye and Zhang, Ye and Yi, Junlin and Luo, Jingwei},
title = {Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline},
journal = {Head & Neck},
year = {2023},
doi = {10.1002/hed.27462}
}
EUVIMED